This HTML5 document contains 11 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

PrefixNamespace IRI
dbpedia-owlhttp://dbpedia.org/ontology/
n6http://commons.wikimedia.org/wiki/Special:FilePath/Sevelamer.png?width=
foafhttp://xmlns.com/foaf/0.1/
rdfshttp://www.w3.org/2000/01/rdf-schema#
n5http://commons.wikimedia.org/wiki/Special:FilePath/Sevelamer.
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
dbpediahttp://dbpedia.org/resource/
Subject Item
dbpedia:Sevelamer
rdfs:comment
Sevelamer (rINN) (/sɛˈvɛləmər/ or /sɛˈvɛləmɪər/) is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. When taken with meals, it binds to dietary phosphate and prevents its absorption. Sevelamer was invented and developed by GelTex Pharmaceuticals. Sevelamer is currently marketed by Sanofi under the trade names Renagel (sevelamer hydrochloride) and Renvela (sevelamer carbonate).
foaf:depiction
n5:png
dbpedia-owl:atcPrefix
V03
dbpedia-owl:atcSuffix
AE02
dbpedia-owl:casNumber
52757-95-6
dbpedia-owl:drugbank
DB00658
dbpedia-owl:fdaUniiCode
941N5DUU5C
dbpedia-owl:iupacName
co-N,N'-diallyl-1,3-diamino-2-hydroxypropane) poly(allylamine-
dbpedia-owl:pubchem
3085017
dbpedia-owl:thumbnail
n6:300